Fatal and Widespread Skeletal Myopathy Confirmed Morphologically Years After Initiation of Simvastatin Therapy

American Journal of Cardiology

Volumn 99, Issue 8, 2007, Pages 1171-1176

  Boltan, David Demitry ^a   Lachar, Whitney ^a   Khetan, Anita ^a   Bouffard, John Paul ^a   Roberts, William Clifford ^a,b  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; IMMUNOGLOBULIN; LISINOPRIL; METHOTREXATE; METOPROLOL; PREDNISONE; SIMVASTATIN; UBIQUINONE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOPSY; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY BYPASS GRAFT; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DYSARTHRIA; DYSPHAGIA; DYSPNEA; HEART INFARCTION; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; LONG TERM CARE; MALE; MUSCLE WEAKNESS; MYOPATHY; PLASMAPHERESIS; PRIORITY JOURNAL; RISK FACTOR; ST SEGMENT ELEVATION; SYMPTOM;

ANTILIPEMIC AGENTS; CALCINOSIS; DEGLUTITION DISORDERS; DYSARTHRIA; DYSPNEA; FATAL OUTCOME; FIBROSIS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MUSCLE FIBERS; MUSCLE WEAKNESS; MUSCULAR DISEASES; NECROSIS; SIMVASTATIN;

EID: 34147152928     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.11.071     Document Type: Article

References (17)

1. Poels P.J.E., and Gabreëls F.J.M. Rhabdomyolysis: a review of the literature. Clin Neurol Neurosurg 95 (1993) 175-192
2. Staffa J.A., Chang J., and Green L. Cerivastitin and reports of fatal rhabdomyolysis. N Engl J Med 346; (2002) 7 539-540
3. Warren J.D., Blumbergs P.C., and Thompson P.D. Rhabdomyolysis: a review. Muscle Nerve 25 (2002) 332-347
4. Ballantyne C.M., Corsini A., Davidson M.H., Holdaas H., Jacobson T.A., Leitersdorf E., März W., Reckless J.P.D., and Stein E.A. Risk for myopathy with statin therapy in high-risk patients. Arch Intern Med 163 (2003) 553-564
5. Abourjaily H.M., Alsheikh-Ali A.A., and Karas R.H. Comparison of the frequency of adverse events in patients treated with atorvastintin or simvastatin. Am J Cardiol 91 (2003) 999-1002
6. Chang J.T., Staffa J.A., Parks M., and Green L. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy. Pharmacoepidemiol Drug Saf 13 (2004) 417-426
7. Graham D.J., Staffa J.A., Shatin D., Andrade S.E., Schech S.D., Grenade L.L., Gurwitz J.H., Chan K.A., Goodman M.J., and Platt R. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA 292 (2004) 2585-2590
8. Grundy S.M. The issue of statin safety: where do we stand?. Circulation 111 (2005) 3016-3019
9. Jones P.H., and Davidson M.H. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin. Am J Cardiol 95 (2005) 120-122
10. Antons K.A., Williams C.D., Baker S.K., and Phillips P.S. Clinical perspectives of statin-induced rhabdomyolysis. Am J Med 119 (2006) 400-409
11. Phillips P.S., Haas R.H., Bannykh S., Hathaway S., Gray N.L., Kimura B.J., Vladutiu G.D., England J.D.F., and Scripps Mercy Clinical Research Center. Statin-associated myopathy with normal creatine kinase levels. Ann Int Med 137 (2002) 581-585
12. Sequeira Carvalho A.A., Lima UW.P., and Valiente R.A. Statin and fibrate associated myopathy: study of eight patients. Arq Neuropsiquiatr 62 2-A (2004) 257-261
13. Baker S.K., Goodwin S., Sur M., and Tarnopolsky M.A. Cytoskeletal myotoxicity from simvastatin and colchicine. Muscle Nerve 30 (2004) 799-802
14. Vasconcelos O.M., and Campbell W.W. Dermatomyositis-like syndrome and HMG-CoA reductase inhibitor (statin) intake. Muscle Nerve 30 (2004) 803-807
15. Trøseid M., Henriksen O.A., and Lindal S. Statin-associated myopathy with normal creatine kinase levels: case report from a Norwegian family. APMIS 113 (2005) 635-637
16. Federman D.G., Hussain F., and Walters J.B. Fatal rhabdomyolysis caused by lipid-lowering therapy. South Med J 94 (2001) 1023-1026
17. Sato Y., Yoneda M., Hayashi K., Nakagawa H., Higuchi I., and Kuriyama M. A steroid-responsive case of severe rhabdomyolysis associated with cytomegalovirus infection. Rinsho Shinkeigaku 46 (2006) 312-316